Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons

BMC Neuroscience

Volumn 9, Issue , 2008, Pages

  Yuan, Wen Ji ^a   Yasuhara, Takao ^a   Shingo, Tetsuro ^a   Muraoka, Kenichiro ^a   Agari, Takashi ^a   Kameda, Masahiro ^a   Uozumi, Takashi ^a   Tajiri, Naoki ^a   Morimoto, Takamasa ^a   Jing, Meng ^a   Baba, Tanefumi ^a   Wang, Feifei ^a   Leung, Hanbai ^a   Matsui, Toshihiro ^a   Miyoshi, Yasuyuki ^a   Date, Isao ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; FREE RADICAL; HYDROETHIDINE; NORPHENAZONE; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE; DOPAMINE; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; PHENAZONE; PHENYLMETHYLPYRAZOLONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EMBRYO; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PARKINSON DISEASE; RAT; SUBSTANTIA NIGRA; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIPYRINE; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; FEMALE; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 51749093977     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-75     Document Type: Article

References (42)

1. Noelker C Bacher M Gocke P Wei X Klockgether T Du Y Dodel R The flavanoide caffeic acid phenethyl ester blocks 6-hydroxydopamine-induced neurotoxicity Neuroscience letters 2005, 383(1-2):39-43. 10.1016/ j.neulet.2005.04.023 15894425
2. Blum D Torch S Lambeng N Nissou M Benabid AL Sadoul R Verna JM Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog Neurobiol 2001, 65(2):135-172. 10.1016/S0301-0082(01)00003-X 11403877
3. Fornstedt B Rosengren E Carlsson A Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species Neuropharmacology 1986, 25(4):451-454. 10.1016/ 0028-3908(86)90242-X 3086766
4. Maruyama W Youdim MB Naoi M Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022 Annals of the New York Academy of Sciences 2001, 939:320-329. 11462787
5. Nie G Jin C Cao Y Shen S Zhao B Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells Archives of biochemistry and biophysics 2002, 397(1):84-90. 10.1006/abbi.2001.2636 11747313
6. Yasuhara T Shingo T Date I The potential role of vascular endothelial growth factor in the central nervous system Reviews in the neurosciences 2004, 15(4):293-307. 15526553
7. Borlongan CV Sanberg PR Elevated body swing test: A new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism J Neurosci 1995, 15(7 Pt 2):5372-5378. 7623159
8. Thakar JH Hassan MN Effects of 6-hydroxydopamine on oxidative phosphorylation of mitochondria from rat striatum, cortex, and liver Can J Physiol Pharmacol 1988, 66(4):376-379. 3139267
9. Galindo MF Jordan J Gonzalez-Garcia C Cena V Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation Journal of neurochemistry 2003, 84(5):1066-1073. 10.1046/j.1471-4159.2003.01592.x 12603830
10. Kawai H Nakai H Suga M Yuki S Watanabe T Saito KI Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model J Pharmacol Exp Ther 1997, 281(2):921-927. 9152402
11. Shichinohe H Kuroda S Yasuda H Ishikawa T Iwai M Horiuchi M Iwasaki Y Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia Brain research 2004, 1029(2):200-206. 10.1016/j.brainres.2004.09.055 15542075
12. Bates B Hirt L Thomas SS Akbarian S Le D Amin-Hanjani S Whalen M Jaenisch R Moskowitz MA Neurotrophin-3 promotes cell death induced in cerebral ischemia, oxygen-glucose deprivation, and oxidative stress: possible involvement of oxygen free radicals Neurobiology of disease 2002, 9(1):24-37. 10.1006/nbdi.2001.0458 11848682
13. Dohi K Satoh K Nakamachi T Yofu S Hiratsuka K Nakamura S Ohtaki H Yoshikawa T Shioda S Aruga T Does edaravone (MCI-186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury? Antioxidants & redox signaling 2007, 9(2):281-287. 10.1089/ ars.2007.9.281 17115943
14. Takahashi G Sakurai M Abe K Itoyama Y Tabayashi K MCI-186 reduces oxidative cellular damage and increases DNA repair function in the rabbit spinal cord after transient ischemia The Annals of thoracic surgery 2004, 78(2):602-607. 10.1016/j.athoracsur.2004.02.133 15276530
15. Banno M Mizuno T Kato H Zhang G Kawanokuchi J Wang J Kuno R Jin S Takeuchi H Suzumura A The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia Neuropharmacology 2005, 48(2):283-290. 10.1016/j.neuropharm.2004.10.002 15695167
16. Yasuhara T Shingo T Kobayashi K Takeuchi A Yano A Muraoka K Matsui T Miyoshi Y Hamada H Date I Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease The European journal of neuroscience 2004, 19(6):1494-1504. 10.1111/j.1460-9568.2004.03254.x 15066146
17. Liu J Narasimhan P Lee YS Song YS Endo H Yu F Chan PH Mild hypoxia promotes survival and proliferation of SOD2-deficient astrocytes via c-Myc activation J Neurosci 2006, 26(16):4329-4337. 10.1523/ JNEUROSCI.0382-06.2006 16624953
18. Paxinos GWG The Rat Brain in Stereotaxic Coordinates San Diego: Academic Press 4, 1998.
19. Date I Felten SY Olschowka JA Felten DL Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice Experimental neurology 1990, 107(3):197-207. 10.1016/ 0014-4886(90)90136-G 2307201
20. Rajesh KG Sasaguri S Suzuki R Maeda H Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression American journal of physiology 2003, 285(5):H2171-2178. 12816747
21. Takayasu Y Nakaki J Kawasaki T Koda K Ago Y Baba A Matsuda T Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain Journal of pharmacological sciences 2007, 103(4):434-437. 10.1254/jphs.SC0070014 17409627
22. Xiao B Bi FF Hu YQ Tian FF Wu ZG Mujlli HM Ding L Zhou XF Edaravone neuroprotection effected by suppressing the gene expression of the Fas signal pathway following transient focal ischemia in rats Neurotox Res 2007, 12(3):155-162, 17967739
23. Qi X Okuma Y Hosoi T Nomura Y Edaravone protects against hypoxia/ ischemia-induced endoplasmic reticulum dysfunction The Journal of pharmacology and experimental therapeutics 2004, 311(1):388-393. 10.1124/ jpet.104.069088 15178695
24. Kawasaki T Kitao T Nakagawa K Fujisaki H Takegawa Y Koda K Ago Y Baba A Matsuda T Nitric oxide-induced apoptosis in cultured rat astrocytes: protection by edaravone, a radical scavenger Glia 2007, 55(13):1325-1333. 10.1002/glia.20541 17626263
25. Tsao CW Cheng JT Lin YS Down-regulation of Bcl-2, activation of caspases, and involvement of reactive oxygen species in 6-hydroxydopamine-induced thymocyte apoptosis Neuroimmunomodulation 2002, 10(6):328-336. 10.1159/000071473 12907839
26. Kawasaki T Ishihara K Ago Y Baba A Matsuda T Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum The Journal of pharmacology and experimental therapeutics 2007, 322(1):274-281. 10.1124/ jpet.106.119206
27. Abe M Kaizu K Matsumoto K A case report of acute renal failure and fulminant hepatitis associated with edaravone administration in a cerebral infarction patient Ther Apher Dial 2007, 11(3):235-240. 10.1111/ j.1744-9987.2007.00480.x 17498008
28. Kawasaki T Ishihara K Ago Y Nakamura S Itoh S Baba A Matsuda T Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum European journal of pharmacology 2006, 542(1-3):92-99. 10.1016/ j.ejphar.2006.05.012 16784740
29. Akiyama Y Miwa S Improvement of postischemic dopaminergic dysfunction by edaravone, a free radical scavenger Journal of pharmacological sciences 2007, 104(1):99-102. 10.1254/jphs.SC0060259 17452805
30. Kumar R Lozano AM Kim YJ Hutchison WD Sime E Halket E Lang AE Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease Neurology 1998, 51(3):850-855. 9748038
31. Patel NK Bunnage M Plaha P Svendsen CN Heywood P Gill SS Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study Ann Neurol 2005, 57(2):298-302. 10.1002/ana.20374 15668979
32. Freed CR Greene PE Breeze RE Tsai WY DuMouchel W Kao R Dillon S Winfield H Culver S Trojanowski JQ Transplantation of embryonic dopamine neurons for severe Parkinson's disease N Engl J Med 2001, 344(10):710-719. 10.1056/NEJM200103083441002 11236774
33. Olanow CW Goetz CG Kordower JH Stoessl AJ Sossi V Brin MF Shannon KM Nauert GM Perl DP Godbold J A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease Ann Neurol 2003, 54(3):403-414. 10.1002/ana.10720 12953276
34. Borlongan CV Sanberg PR Freeman TB Neural transplantation for neurodegenerative disorders Lancet 1999, 353(Suppl 1):SI29-30. 10319932
35. Dezawa M Kanno H Hoshino M Cho H Matsumoto N Itokazu Y Tajima N Yamada H Sawada H Ishikawa H Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation The Journal of clinical investigation 2004, 113(12):1701-1710. 420509 15199405
36. Takagi Y Takahashi J Saiki H Morizane A Hayashi T Kishi Y Fukuda H Okamoto Y Koyanagi M Ideguchi M Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model The Journal of clinical investigation 2005, 115(1):102-109. 539189 15630449
37. Yasuhara T Matsukawa N Hara K Yu G Xu L Maki M Kim SU Borlongan CV Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease J Neurosci 2006, 26(48):12497-12511. 10.1523/JNEUROSCI.3719-06.2006 17135412
38. Takahashi K Yamanaka S Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 2006, 126(4):663-676. 10.1016/j.cell.2006.07.024 16904174
39. Redmond DE Jr Bjugstad KB Teng YD Ourednik V Ourednik J Wakeman DR Parsons XH Gonzalez R Blanchard BC Kim SU Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells Proceedings of the National Academy of Sciences of the United States of America 2007, 104(29):12175-12180. 1896134 17586681 10.1073/pnas.0704091104
40. Muraoka K Shingo T Yasuhara T Kameda M Yuen WJ Uozumi T Matsui T Miyoshi Y Date I Comparison of the therapeutic potential of adult and embryonic neural precursor cells in a rat model of Parkinson disease Journal of neurosurgery 2008, 108(1):149-159. 10.3171/JNS/2008/108/01/0149 18173325
41. Zhang W Sato K Hayashi T Omori N Nagano I Kato S Horiuchi S Abe K Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain Neurological research 2004, 26(3):342-348. 10.1179/016164104225014058 15142331
42. Nelson SK Bose S Rizeq M McCord JM Oxidative stress in organ preservation: A multifaceted approach to cardioplegia Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2005, 59(4):149-157. 10.1016/j.biopha.2005.03.007 15862708